DIA Biosimilars 2013

Articles Published in 2010

UBC Opens Office In Germany

Thursday, July 1, 2010 07:59 AM

United BioSource Corporation (UBC) launched a new office in Lörrach, Germany, further expanding the company’s clinical research and medical affairs capabilities in Europe.

More... »

Cenduit: Now with Patient Reminders

AAHRPP Accredits Eight Institutions

Wednesday, June 30, 2010 07:52 AM

The Association for the Accreditation of Human Research Protection Programs (AAHRPP) has expanded accreditation in the U.S. and internationally, as a diverse group of hospitals, inde-pendent institutional review boards, and an academic center earned accreditation at the June meeting of its Council on Accreditation.

More... »

CRF Health – eCOA Forum

Quintiles Expands Number of Strategic Site Relationship Managers

Tuesday, June 29, 2010 07:49 AM

After seeing how a little extra contact with investigative sites improved study-start up times and enrollment, Quintiles has doubled its number of strategic site relationship managers (SSRMs) in the past eight months.

More... »

Kendle Opens New Operations Center in India

Monday, June 28, 2010 09:03 AM

Global contract research organization Kendle has opened its new operations center in the special economic zone (SEZ) of the Ahmedabad-Gandhinagar Knowledge Corridor. The new SEZ center represents a strategic investment for Kendle and demonstrates the company's commitment to further invest in Asia/Pacific region.

More... »

BBK Introduces Patient Recruitment Franchise Program

Friday, June 25, 2010 08:55 AM

BBK Worldwide expanded its three decades of expertise in supporting clinical R&D with the introduction of its patient recruitment franchise program at the DIA Annual Meeting in Washington, D.C.

More... »

Covance Opens Biorepository in Indiana

Thursday, June 24, 2010 08:51 AM

Covance, a global contract research organization (CRO), has opened a state-of-the-art biorepository facility at its Greenfield, Ind. location.

More... »

SAFE-BioPharma Signing up Sites, CROs

Wednesday, June 23, 2010 08:48 AM

Contract research organizations (CROs) and investigative sites have begun to adopt SAFE-BioPharma digital identities, which are already widely used by biopharmaceutical companies, in order to sign contracts and other clinical trial documents electronically.

More... »

RPS to Raise $100 Million in IPO

Wednesday, June 23, 2010 08:15 AM

ReSearch Pharmaceutical Services (RPS) plans an initial public offering in the U.S. on the Nasdaq exchange. The Fort Washington, Pa.-based contract research organization (CRO ) seeks to raise $100 million from the IPO.

More... »

Parexel Hires Former FDA, MHRA Regulators

Tuesday, June 22, 2010 10:01 AM

Parexel Consulting, a business unit of Parexel International, has appointed former regulators Toby Silverman, M.D. and Keith Watson, Ph.D. as principal consultants.

More... »

PPD Names CIO and EVP for Global Clinical Development

Monday, June 21, 2010 09:45 AM

Contract research organization PPD appointed Mike Wilkinson, Ph.D., as executive vice president and chief information officer and Paul Colvin as executive vice president of global clinical development.

More... »

`
CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs